Search Orphan Drug Designations and Approvals
-
Generic Name: | CD3 and B-cell maturation antigen T-cell engaging bispecific antibody |
---|---|
Date Designated: | 10/17/2019 |
Orphan Designation: | Treatment of Multiple Myeloma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
TeneoOne, Inc. 1 North Waukegan Road North Chicago, Illinois 60064 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-